loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Tazobactam Sodium

    Menu

    Tazobactam Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 136Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 50684 / DOSAGE - INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PIPERACILLIN SODIUM(UNII: M98T69Q7HP)
    (PIPERACILLIN - UNII:X00B0D5O0E)     		PIPERACILLIN3.0g in 15
    TAZOBACTAM SODIUM(UNII: UXA545ABTT)
    (TAZOBACTAM - UNII:SE10G96M8W)     		TAZOBACTAM0.375g in 15

    Inactive Ingredients

    Ingredient Name
    Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
    Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
    Cardinal Health
    Wyeth Piperacillin Division of Wyeth Holdings Corporation, a subsidiary of Pfizer
    DEXTROSE MONOHYDRATE(LX22YL083G)  
    EDETATE DISODIUM(7FLD91C86K)
    HYDROCHLORIC ACID(QTT17582CB)  
    SODIUM BICARBONATE(8MDF5V39QO)  
    SODIUM CITRATE(1Q73Q2JULR) 
    SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)  
    WATER(059QF0KO0R)